Sodium Zirconium Cyclosilicate

CHEMBL3301592 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
365.4 g/mol
LogP
Phase
4

Sodium zirconium cyclosilicate is a selective potassium-capturing ion exchange compound used for the treatment of hyperkalemia in chronic kidney disease and heart failure. The microporous zirconium silicate framework selectively captures potassium ions (and ammonium ions) in the gastrointestinal tract in exchange for sodium and hydrogen ions, reducing intestinal potassium absorption and lowering serum potassium levels. Unlike older potassium binders, it has high selectivity for potassium over calcium and magnesium.

Masse moléculaire

365,4500 g/mol

TPSA

166,00 Ų

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

[O-][Si]1(O[Si](O[Si](O1)([O-])[O-])([O-])[O-])[O-].[Na+].[Na+].[Zr+4]

InChI

InChI=1S/2Na.O9Si3.Zr/c;;1-10(2)7-11(3,4)9-12(5,6)8-10;/q2*+1;-6;+4

Molecular Formula

Na2O9Si3Zr

HBD / HBA

- / 9

Liaisons Rotatives

0

Atomes Lourds

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Sodium zirconium cyclosilicate is a selective potassium-capturing ion exchange compound used for the treatment of hyperkalemia in chronic kidney disease and heart failure. The microporous zirconium silicate framework selectively captures potassium ions (and ammonium ions) in the gastrointestinal tract in exchange for sodium and hydrogen ions, reducing intestinal potassium absorption and lowering serum potassium levels. Unlike older potassium binders, it has high selectivity for potassium over calcium and magnesium.

Yes, Sodium Zirconium Cyclosilicate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3301592. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 155804812. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.